Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial

Management of Major Depressive Disorder (MDD) might be improved by a biomarker to predict whether a selected medication is likely to lead to remission. We previously reported on a quantitative electroencephalogram-based biomarker, the Antidepressant Treatment Response (ATR) index, that integrated re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of psychiatric research 2020-05, Vol.124, p.159-165
Hauptverfasser:	Cook, Ian A., Hunter, Aimee M., Caudill, Marissa M., Abrams, Michelle J., Leuchter, Andrew F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antidepressants Biomarkers Citalopram - therapeutic use Depressive Disorder, Major - drug therapy Drug response biomarkers EEG Humans Major depressive disorder Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!